HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandra Bitto Selected Research

Raxofelast

7/2005Lipid peroxidation inhibition by raxofelast improves angiogenesis and wound healing in experimental burn wounds.
4/2005Protective effects of antioxidant raxofelast in alcohol-induced liver disease in mice.
10/2004Raxofelast, a hydrophilic vitamin E-like antioxidant, reduces testicular ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandra Bitto Research Topics

Disease

21Wounds and Injuries (Trauma)
10/2021 - 08/2004
15Inflammation (Inflammations)
01/2022 - 07/2010
13Ischemia
10/2021 - 10/2004
11Reperfusion Injury
01/2016 - 04/2004
10Necrosis
02/2021 - 03/2006
9Neoplasms (Cancer)
11/2021 - 04/2004
9Ischemic Stroke
04/2012 - 03/2006
8Systemic Scleroderma (Systemic Sclerosis)
01/2022 - 08/2013
7Multiple Myeloma
11/2021 - 01/2016
7Atherosclerosis
01/2020 - 05/2004
7Shock
04/2012 - 11/2005
7Brain Ischemia (Cerebral Ischemia)
04/2012 - 03/2006
6Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 04/2004
6Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2017 - 03/2009
6Osteoporosis
02/2017 - 04/2004
5Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 08/2013
5Fibrosis (Cirrhosis)
01/2022 - 08/2013
5Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2021 - 03/2006
5Insulin Resistance
01/2017 - 03/2005
5Sepsis (Septicemia)
01/2015 - 07/2010
5Stroke (Strokes)
11/2011 - 05/2006
4Hypoxia (Hypoxemia)
10/2021 - 10/2009
4Traumatic Brain Injuries (Traumatic Brain Injury)
08/2020 - 03/2012
4Burns
01/2015 - 07/2005
4Spermatic Cord Torsion (Testicular Torsion)
04/2009 - 10/2004
3COVID-19
04/2022 - 04/2021
3Heart Failure
04/2022 - 01/2021
3Hypertension (High Blood Pressure)
01/2022 - 11/2004
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2021 - 10/2016
3Obesity
07/2021 - 11/2004
3Colitis
10/2020 - 01/2016
3Chronic Disease (Chronic Diseases)
10/2020 - 04/2004
3Weight Loss (Weight Reduction)
08/2020 - 10/2016
3Ulcer
01/2018 - 10/2009
3Edema (Dropsy)
01/2018 - 07/2008
3Bone Resorption
01/2017 - 01/2004
3Pancreatitis
11/2014 - 10/2004
3Myocardial Ischemia (Ischemic Heart Diseases)
04/2012 - 11/2005

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
01/2018 - 08/2004
19Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 08/2004
18GenisteinIBA
06/2017 - 04/2004
14salicylhydroxamic acid (SHAM)IBA
02/2020 - 07/2004
14MelanocortinsIBA
10/2014 - 11/2005
14Messenger RNA (mRNA)IBA
12/2013 - 09/2004
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2015 - 03/2006
9PolydeoxyribonucleotidesIBA
10/2021 - 05/2008
9flavocoxidIBA
01/2021 - 12/2009
9Phosphotransferases (Kinase)IBA
01/2018 - 02/2005
8Purinergic P1 Receptors (Adenosine Receptor)IBA
07/2021 - 10/2009
8NF-kappa B (NF-kB)IBA
11/2010 - 03/2006
7InflammasomesIBA
08/2020 - 05/2014
7IsoflavonesIBA
01/2020 - 08/2007
7Mitogen-Activated Protein KinasesIBA
11/2014 - 02/2005
7Peptides (Polypeptides)IBA
04/2012 - 11/2005
6Interleukin-6 (Interleukin 6)IBA
04/2022 - 04/2009
6Hormones (Hormone)IBA
01/2020 - 04/2004
6Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
11/2015 - 11/2005
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 04/2006
5Biological ProductsIBA
11/2021 - 01/2018
5Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 01/2011
5CytokinesIBA
10/2021 - 03/2003
5AntioxidantsIBA
01/2017 - 10/2004
5Melanocyte-Stimulating Hormones (MSH)IBA
03/2014 - 02/2011
5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2012 - 07/2005
4caryophylleneIBA
11/2021 - 01/2019
4CateninsIBA
11/2021 - 01/2018
4Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
10/2021 - 03/2011
4CollagenIBA
10/2021 - 08/2004
4Biomarkers (Surrogate Marker)IBA
08/2020 - 08/2013
4LipopolysaccharidesIBA
01/2019 - 07/2008
4oxidized low density lipoproteinIBA
01/2016 - 05/2004
4EnzymesIBA
11/2014 - 05/2004
4Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
10/2014 - 03/2006
4Glucose (Dextrose)FDA LinkGeneric
10/2012 - 03/2005
4Neuroprotective AgentsIBA
03/2012 - 03/2006
4Interleukin-10 (Interleukin 10)IBA
03/2012 - 07/2010
4alpha-MSHIBA
08/2009 - 03/2006
4Mitogen-Activated Protein Kinase 3IBA
02/2009 - 10/2004
4JNK Mitogen-Activated Protein KinasesIBA
07/2007 - 10/2004
3Pharmaceutical PreparationsIBA
07/2021 - 10/2020
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 02/2008
3dinitrobenzenesulfonic acidIBA
10/2020 - 01/2016
32,4-dinitrofluorobenzene sulfonic acidIBA
10/2020 - 01/2016
3Interleukin-18 (Interleukin 18)IBA
08/2020 - 11/2010
3Malondialdehyde (Propanedial)IBA
02/2018 - 11/2015
3NitritesIBA
02/2018 - 07/2005
3Simvastatin (Zocor)FDA LinkGeneric
01/2016 - 02/2008
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2016 - 02/2005
3DystrophinIBA
09/2015 - 03/2006
3Insulin (Novolin)FDA Link
10/2012 - 03/2005
3Fibrinogen (Factor I)FDA Link
10/2012 - 03/2005
3Cholinergic Agents (Cholinergics)IBA
10/2011 - 11/2005
3LipidsIBA
03/2009 - 04/2006
3OsteoprotegerinIBA
05/2008 - 03/2005
3ErythropoietinFDA Link
04/2006 - 08/2004

Therapy/Procedure

5Therapeutics
01/2022 - 10/2016
4Injections
09/2013 - 10/2004
3Ligation
01/2015 - 04/2012
3Punctures
01/2015 - 04/2012
3Treatment Delay
08/2009 - 03/2006